Ep0162 50088 — Washington D.C., District of Columbia

Ep0162 50088 is a clinical research site located in Washington D.C., District of Columbia, United States 20037.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Ep0162 50088 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Stereotypical Prolonged Seizures.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ep0162 50088?

Ep0162 50088 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ep0162 50088 conducted?

Ep0162 50088 has 1 clinical trials on record, with 1 currently active. Their work covers Stereotypical Prolonged Seizures.

Is Ep0162 50088 accredited by Crixeo Health?

Ep0162 50088 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ep0162 50088?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.